Advertisement
IRVINE, Calif., Nov. 21, 2019 /PRNewswire-PRWeb/ -- StudyKIK, a patient recruitment and technology company that builds patient enrollment and communication solutions for clinical trials, has furthered its commitment to supporting research sites with the newest release of its Patient Qualification Suite technology platform. The "Patient Qualification Department" was created to support sites by reducing their workload, and increase the quality of patient referrals. StudyKIK's site partners have long expressed the desire to place their full attention on patients that are pre-qualified and have voiced a strong interest in their study. By removing the time-consuming process of screening a high volume of referrals, sites can focus on their patients that are progressing through the trial. The new technology update to the Patient Qualification Suite allows StudyKIK's agents to support sites in this regard by adding a patient queue system, instant messaging, streamlined UI, detailed patient and protocol information, and complete integration into over 3,000 research site's, hospital's, and universities' StudyKIK portals. These improvements have increased our agents' efficiency by 90% and improved the quality of our pre-screening. This makes more screening data available for research sites after a patient is warm-transferred and makes scheduling patients faster and easier than ever before.
Chris Caldron, Director of Patient Qualification at StudyKIK stated;
"This new update to our Patient Qualification Platform was designed to maximize our recruitment speed and efficiency in engaging with patients. Our qualification agents will spend much more time on the phones with patients, connecting within minutes of signing up, instead of being worried about keeping track of a list of patients and when they need to be called. The goal is to engage with 100% of new patients interested in joining a research study immediately, while they're still available and the study is top-of-mind. We are already seeing this produce a higher conversion rate of interested patients, and quicker delivery of qualified patients to the research sites we support."
This latest version of the Patient Qualification Suite technology platform is designed to connect StudyKIK's call center agents to the right patient at the right time. By introducing the Patient Queue, each qualification agent's tasks are automatically sorted by importance, ensuring that scheduling an appointment for a qualified patient is prioritized over an initial outreach call. Patient text messaging has also seen significant improvements, from pre-drafted quick messages to mobile number confirmation. Additional improvements to the software suite includes a built-in pre-screener that corresponds to the study's protocol and an integrated Caller ID system.
Continuing its longstanding dedication to supporting research sites, pharmaceutical sponsors, and CROs, StudyKIK's newly upgraded Patient Qualification Technology Suite improves patient connectivity to sites by 82%. With all patient data fully integrated within the StudyKIK portal, both site and sponsor partners can track each patient from referral to pre-qualification and their first scheduled visit. Having recruitment data readily available equips key decision-makers with the information needed to ensure that their trial is successfully enrolled.
More about StudyKIK:
StudyKIK is a patient recruitment and technology platform that was founded on patient communities on all major social media channels to increase awareness for clinical trials. Servicing over 3,000 research site users, StudyKIK owns hundreds of social media patient and caregiver communities across Instagram, Snapchat, Facebook, Twitter, and Pinterest to connect patients to clinical trials. They have addressed the clinical trial patient recruitment problem by building the technology solutions needed for research sites and pharmaceutical companies to access, manage, and communicate with high-quality patients in real-time.
SOURCE StudyKIK
Advertisement
Chris Caldron, Director of Patient Qualification at StudyKIK stated;
"This new update to our Patient Qualification Platform was designed to maximize our recruitment speed and efficiency in engaging with patients. Our qualification agents will spend much more time on the phones with patients, connecting within minutes of signing up, instead of being worried about keeping track of a list of patients and when they need to be called. The goal is to engage with 100% of new patients interested in joining a research study immediately, while they're still available and the study is top-of-mind. We are already seeing this produce a higher conversion rate of interested patients, and quicker delivery of qualified patients to the research sites we support."
This latest version of the Patient Qualification Suite technology platform is designed to connect StudyKIK's call center agents to the right patient at the right time. By introducing the Patient Queue, each qualification agent's tasks are automatically sorted by importance, ensuring that scheduling an appointment for a qualified patient is prioritized over an initial outreach call. Patient text messaging has also seen significant improvements, from pre-drafted quick messages to mobile number confirmation. Additional improvements to the software suite includes a built-in pre-screener that corresponds to the study's protocol and an integrated Caller ID system.
Continuing its longstanding dedication to supporting research sites, pharmaceutical sponsors, and CROs, StudyKIK's newly upgraded Patient Qualification Technology Suite improves patient connectivity to sites by 82%. With all patient data fully integrated within the StudyKIK portal, both site and sponsor partners can track each patient from referral to pre-qualification and their first scheduled visit. Having recruitment data readily available equips key decision-makers with the information needed to ensure that their trial is successfully enrolled.
More about StudyKIK:
StudyKIK is a patient recruitment and technology platform that was founded on patient communities on all major social media channels to increase awareness for clinical trials. Servicing over 3,000 research site users, StudyKIK owns hundreds of social media patient and caregiver communities across Instagram, Snapchat, Facebook, Twitter, and Pinterest to connect patients to clinical trials. They have addressed the clinical trial patient recruitment problem by building the technology solutions needed for research sites and pharmaceutical companies to access, manage, and communicate with high-quality patients in real-time.
SOURCE StudyKIK
